Aquestive Therapeutics, Inc. AQST Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License and royalty revenue a | $7.79M-4.2% | $8.12M+131% | $3.52M+0.6% | $3.5M-24.3% | $4.62M-69.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Aquestive Therapeutics, Inc. break its business down?
- Aquestive Therapeutics, Inc. (AQST) reports revenue by product across 4 parts — Co-development and research fees, License and royalty revenue a, Manufacture and supply revenue and Proprietary product revenue, net. Each is extracted from the segment footnotes and tracked over time.
- Where does Aquestive Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Aquestive Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
